Lisa LaVange, Ph.D.
Professor Emerita and Former Chair
Department of Biostatistics
Gillings School of Global Public Health
University of North Carolina at Chapel Hill

About Lisa
Lisa LaVange, PhD, is Professor Emerita and former Chair of Biostatistics at the University of North Carolina at Chapel Hill and an independent statistical consultant in global drug development and regulatory review. From 2011 to 2017, Dr. LaVange was director of the Office of Biostatistics in the US FDA’s Center for Drug Evaluation and Research (CDER) where she was oversaw more than 200 statisticians involved in the review of new drugs, therapeutic biologics, and generics. She established FDA’s complex innovative design initiative and continues to contribute to research in innovative clinical trials design and analysis. Prior to her government and academic experience, she spent 16 years in non-profit research and 10 years as senior executive in the pharmaceutical and contract research organization industry. Dr. LaVange is an elected fellow of the American Statistical Association (ASA), served as the 2018 ASA President and Board Chair, and is recipient of numerous awards for her contributions to drug development and international regulatory harmonization.

• Dr. Lisa LaVange was appointed on May, 2019 as a Board of Director.